Table: Oncolys Biopharma - 9-MTH parent results

Oncolys Biopharma

10/11/2023 06:00

Nov 10 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2023        Sep 30, 2022     Dec 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            63 mln              784 mln                    
                 (-92.0 pct)                                      
  Operating       loss 1.31         loss 937 mln                  
  Recurring       loss 1.27         loss 854 mln                  
  Net             loss 1.27         loss 835 mln                  
  EPS          loss 73.15 yen      loss 48.20 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T